News | April 19, 2010

FTC Sponsors Fibroid Awareness Week

April 19, 2010 – The Fibroid Treatment Collective (FTC) has launched an annual observance called Fibroid Awareness Week scheduled this year for April 19-23, which is dedicated to education about fibroids that affect upwards of 50 percent of all women.
Concern for the high number of unnecessary hysterectomies and dissatisfaction with other treatment outcomes led Bruce McLucas, M.D., founder of the collective and a board certified obstetrician and gynecologist, to become a non-surgical treatment advocate. His goal, and the mission of FTC, is to ensure women with fibroids know all the options when it comes to treatment. FTC advocates embolization as a safe alternative to other fibroid treatments.

In gynecology, embolization is used to reduce bleeding during uterine surgery. Founding members of the Fibroid Treatment Collective also noticed it shrinks fibroids. The promise of an effective, noninvasive treatment led to research, trials and medical acceptance. Today more than several hundred thousand women world-wide have found relief with this safe, simple procedure. The Fibroid Treatment Collective performed the very first fibroid embolization in America, and has perfected the procedure with thousands of successful treatments to date. Dr. McLucas is one of the only gynecologists in America accredited in the skills necessary to perform embolization.

Several special events will highlight the week, including a Fibroid Treatment Seminar on Wednesday, April 21 in Pasadena, Calif., at 6:00 p.m. and a national Fibroid Treatment Webinar, at 5 p.m., Friday, April 23. Both are free, and reservations can be made at www.fibroids.com.

Uterine fibroids can affect women of all ages, but are most common in women ages 40 to 50. “We felt the best way to reach out to almost half the women around the world who may have symptoms of fibroids was through an annual educational observance and to disseminate accurate and timely information about diagnosis and treatment,” said McLucas. “The Fibroid Treatment Collective was founded 12 years ago to educate women about fibroids and various treatment options,” he added.

Women interested in learning more about Fibroid Awareness Week can join a national live chat Monday through Friday from 9 a.m. - 5 p.m. PST at www.fibroids.com.

For more information: www.fibroids.com

Related Content

RSNA Study Shows Real-Time Indicator Improves Mammographic Compression
News | Mammography | December 12, 2018
Sigmascreening recently announced that more than 100,000 women have had mammography exams with the Sensitive Sigma...
Massachusetts Superior Court Grants Hologic Preliminary Injunction in Trade Secrets Lawsuits
News | Mammography | December 12, 2018
December 12, 2018 — A Massachusetts Superior Court granted a preliminary injunction in lawsuits by Hologic against Ch
Videos | Mammography | December 10, 2018
Stamatia Destounis, M.D., FACR, associate professor, University of Rochester School of Medicine, and attending radiol
FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...
Fujifilm Collaborates With Lunit on AI Pilot Project
News | Artificial Intelligence | December 05, 2018
Fujifilm Medical Systems USA Inc. announced a joint collaboration with Korean-based medical artificial intelligence (AI...
ScreenPoint Medical and Volpara Partner to Bring AI to Breast Imaging Clinics
News | Computer-Aided Detection Software | December 04, 2018
ScreenPoint Medical has signed a memorandum of understanding (MOU) with Volpara Health Technologies. Volpara will...
GE Healthcare Introduces Invenia ABUS 2.0
Technology | Ultrasound Women's Health | December 03, 2018
GE Healthcare recently launched the Invenia automated breast ultrasound (ABUS) 2.0 system in the United States. This...
Snoring Poses Greater Cardiac Risk to Women
News | Women's Health | November 29, 2018
Obstructive sleep apnea (OSA) and snoring may lead to earlier impairment of cardiac function in women than in men,...
ScreenPoint Medical Receives FDA Clearance for Transpara Mammography AI Solution
Technology | Computer-Aided Detection Software | November 28, 2018
November 28, 2018 — ScreenPoint Medical announced it has received 510(k) clearance from the U.S.
Women Benefit From Mammography Screening Beyond Age 75
News | Mammography | November 26, 2018
Women age 75 years and older should continue to get screening mammograms because of the comparatively high incidence of...